Download Case Report Section

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Comparative genomic hybridization wikipedia , lookup

Mutagen wikipedia , lookup

NEDD9 wikipedia , lookup

Oncogenomics wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Hybrid (biology) wikipedia , lookup

Genome (book) wikipedia , lookup

Meiosis wikipedia , lookup

Skewed X-inactivation wikipedia , lookup

Molecular Inversion Probe wikipedia , lookup

Medical genetics wikipedia , lookup

Y chromosome wikipedia , lookup

Ploidy wikipedia , lookup

X-inactivation wikipedia , lookup

Chromosome wikipedia , lookup

Neocentromere wikipedia , lookup

Polyploid wikipedia , lookup

Karyotype wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Case Report Section
Paper co-edited with the European LeukemiaNet
t(3;4)(p21;q34) as a sole anomaly in acute myeloid
leukemia patient
Adriana Zamecnikova
Kuwait Cancer Control Center, Laboratory of Cancer Genetics, Department of Hematology, Shuwaikh,
70653, Kuwait
Published in Atlas Database: May 2007
Online updated version is available from: http://AtlasGeneticsOncology.org/Reports/0304ZamecnikovaID100026.html
DOI: 10.4267/2042/38513
This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence.
© 2008 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Treatment: Allopurinol, Hydroxyurea, Tazocin,
Amikacin (ADE 10, ADE 8).
Complete remission: None;
Treatment related death: -;
Relapse: -;
Phenotype at relapse: -;
Status: Alive (05-2007 traveled to receive BMT,
allogenic BMT on 29-08-06);
Survival: 12 months.
Clinics
Age and sex: 32 years old male patient.
Previous History:
- no preleukemia;
- no previous malignant disease;
- no inborn condition of note.
Organomegaly:
- hepatomegaly;
- splenomegaly;
- enlarged lymph nodes;
- no central nervous system involvement.
Karyotype
Sample: BM; Culture time: 24h; Banding: G-band.
Results: 46,XY,t(3;4)(p21;q34)
Other molecular cytogenetic techniques: Fluorescence
in situ hybridisation (FISH), with WCP 3 and 4 probes
to confirm the t(3;4). To confirm the translocation of 3p
and to exclude the translocation t(3;5)(q25;q34-35)
FISH studies with LSI BCL6 and EGR1 SO/D5S23
probes were performed (Vysis, Downers Grove IL,
USA).
Other molecular cytogenetics results: Using WCP 3
and 4 probes we confirmed the rearranged
chromosomes 3 and 4. Analysis with LSI BCL6 probe
revealed one red/green fusion signal on the 3q27 allele
in the normal chromosome 3, and a fusion signal on the
long arm of the der(3). Hybridization with LSI 5q
SpectrumOrange/5p SpectrumGreen probe revealed 2
normal chromosomes 5, excluding the rearrangement
of chromosome 5.
Blood
WBC: 68.4 x 109/l; Hb: 11.7 g/dl; platelets: 120 x 109/l;
blasts: 93%
Bone marrow: Markedly hypercellular, erythropoiesis
depressed, leucopoiesis hyperplastic, 83.5% blasts (PM
1%, MY 2%, MM 3.5%, Po 0.5%, Ly 6.5%, Mono 2%,
Eb 1%), near total replacement by blasts,
megakaryocytes depressed, occasionally Auer rods
seen.
Cytopathology classification
Cytology: Acute myeloid leukemia
Immunophenotype: Positive for CD 34, HLDR, CD33,
CD34, CD68, myeloperoxidase.
Rearranged Ig or Tcr: Pathology: Electron microscopy: Precise diagnosis: Acute myeloid leukemia, M1.
Other findings
Results: LDH almost 3 folds upper normal limit.
Survival
Date of diagnosis: 05-2006.
Atlas Genet Cytogenet Oncol Haematol. 2008;12(2)
182
t(3;4)(p21;q34) as a sole anomaly in acute myeloid leukemia patient
Zamecnikova A
On the basis of these morphological findings, a
diagnosis of acute myeloid leukemia (FAB-M1 type)
was made.
3p21 is a recurrent breakpoint in MDS/AML and tMDS/t-AML suggesting, 3p21 site is likely to contain a
gene (genes) involved in the pathogenesis of
t(3;4)(p21;q34). One previous case of t(3;4)(p21;q34)
was found in a refractory anemia, making this anomaly
recurrent. The similar cytogenetic appearance of a rare
t(3;4)(p21;q34) and the more frequent t(3;5)(q25;q34)
in suboptimal preparations reinforces the utility of
FISH
technique
for
assessing
chromosomal
abnormalities in AML.
Comments
A 31-year-old Kuwaiti male presented with 3-months
history of fatigue, recurrent sore throat attacks and a 2day history of recurrent vomiting and loose motions.
Physical examinations revealed left cervical
lymphadenopaty and hepatosplenomegaly. Laboratory
investigations showed Hb 11.7g/dl, platelets 120x109l
and white blood cells 68.4x109l. Bone marrow smears
were markedly hypercellular with 93% large blast cells.
Cytochemical studies showed myeloperoxydase
positive (60%), Sudan Black B positive (74.6%), PAS
and non-specific esterase negative blast cells.
Partial karyotypes (G-banding) demonstrating rearrangened chromosomes 3 and 4.
Atlas Genet Cytogenet Oncol Haematol. 2008;12(2)
183
t(3;4)(p21;q34) as a sole anomaly in acute myeloid leukemia patient
Zamecnikova A
Whole chromosome paintings with rearrangened chromosomes 3 and 4 and hybridization with LSI BCL6 and LSI 5qSO/5pSG probes
showing the fusion signal on normal chromosome 3 and on der(3) chromosome and two normal chromosomes 5.
patients with del(20q): prognosis revisited. Cancer Genet
Cytogenet 2006;171:9-16.
References
Shi G, Weh HJ, Martensen S, Seeger D, Hossfeld DK. 3p21 is
a recurrent treatment-related breakpoint in myelodysplastic
syndrome and acute myeloid leukemia. Cytogenet Cell Genet
1996;74:295-299.
This article should be referenced as such:
Zamecnikova A. t(3;4)(p21;q34) as a sole anomaly in acute
myeloid leukemia patient. Atlas Genet Cytogenet Oncol
Haematol.2008;12(2):182-184.
Liu YC, Ito Y, Hsiao HH, Sashida G, Kodama A, Ohyashiki JH,
Ohyashiki K. Risk factor analysis in myelodysplastic syndrome
Atlas Genet Cytogenet Oncol Haematol. 2008;12(2)
184
Related documents
Leukaemia Section t(9;11)(q34;p15) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;11)(q34;p15) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;4)(p21;q34) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;4)(p21;q34) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;5)(q25;q34)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34) Atlas of Genetics and Cytogenetics
Gene Section SET (SET translocation
Gene Section SET (SET translocation
Leukaemia Section t(9;9)(q34;q34) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;9)(q34;q34) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Gene Section LCP1 (lymphocyte cytosolic protein1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(4;21)(q31;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(4;21)(q31;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;4)(q27;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;4)(q27;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(16;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(16;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section CRTC1 (CREB regulated transcription coactivator 1) Atlas of Genetics and Cytogenetics
Gene Section CRTC1 (CREB regulated transcription coactivator 1) Atlas of Genetics and Cytogenetics
Leukaemia Section del(9q) solely Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section del(9q) solely Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section i(5)(p10) in acute myeloid leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section i(5)(p10) in acute myeloid leukemia Atlas of Genetics and Cytogenetics
Case Report Section
Case Report Section
Leukaemia Section 1q translocations (unbalanced) in myeloid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section 1q translocations (unbalanced) in myeloid malignancies Atlas of Genetics and Cytogenetics
Gene Section GATA2 (GATA binding protein 2) Atlas of Genetics and Cytogenetics
Gene Section GATA2 (GATA binding protein 2) Atlas of Genetics and Cytogenetics
Leukaemia Section Atypical chronic myeloid leukemia (aCML) Atlas of Genetics and Cytogenetics
Leukaemia Section Atypical chronic myeloid leukemia (aCML) Atlas of Genetics and Cytogenetics
Leukaemia Section del(13q) in myeloid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section del(13q) in myeloid malignancies Atlas of Genetics and Cytogenetics
Gene Section SSX2IP (synovial sarcoma, X breakpoint 2 interacting protein)
Gene Section SSX2IP (synovial sarcoma, X breakpoint 2 interacting protein)
Leukaemia Section i(17q) solely in myeloid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section i(17q) solely in myeloid malignancies Atlas of Genetics and Cytogenetics